Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.
about
Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia.Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study.β-lactam/β-lactamase inhibitor combinations: from then to now.Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
P2860
Q35076892-FE216EB0-ADE1-490F-B1C7-65BAF05A8ADAQ36290474-15ECE292-900A-4C83-B29F-A238B03EE130Q36290815-8729D090-38EE-43A9-833D-10CAFE51249BQ36644601-8C5793D8-344E-495B-87C3-AAB82D00618EQ37597301-595FD3E7-42EA-44A3-8D89-E724D5452FFDQ38264182-B8DC5B58-8F79-46F5-8960-5DC97F478C4AQ38626553-79580EAE-2980-40BB-B427-43449C320C89Q38739545-DA2FEC55-9CC3-4805-882D-B30D92EBC257Q38741453-A0EAE228-906D-4177-9253-7D701CA16B74Q38742676-E47EB7DA-15C9-47DA-A4AF-162C15C319F3Q38981397-25A9E3D0-41C0-4A60-B633-42481931AF20Q47312597-B2AC64E5-C781-41E4-9AF8-97B641C49A6CQ50080905-C09AF8AA-DFBA-46D6-8512-2A005D34E982Q54215649-845634E8-BA4C-4995-92FC-DF37A0A745E5
P2860
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cefepime vs other antibacteria ...... terobacter species bacteremia.
@ast
Cefepime vs other antibacteria ...... terobacter species bacteremia.
@en
type
label
Cefepime vs other antibacteria ...... terobacter species bacteremia.
@ast
Cefepime vs other antibacteria ...... terobacter species bacteremia.
@en
prefLabel
Cefepime vs other antibacteria ...... terobacter species bacteremia.
@ast
Cefepime vs other antibacteria ...... terobacter species bacteremia.
@en
P2093
P2860
P356
P1476
Cefepime vs other antibacteria ...... terobacter species bacteremia.
@en
P2093
Belisa B Guzmán-Suarez
David C Hooper
David W Kubiak
Mark J Siedner
Mary Jane Ferraro
Nour Baghdady
Thomas F O'Brien
P2860
P304
P356
10.1093/CID/CIU182
P407
P577
2014-03-18T00:00:00Z